CD9 (PN0226) Nb-FC recombinant antibody

Alias:B3GAT1;GLCATP;Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1;Beta-1;3-glucuronyltransferase 1;Glucuronosyltransferase P;GlcAT-P;UDP-GlcUA:glycoprotein beta-1;3-glucuronyltransferase;GlcUAT-P;CD57 nanobody;

CatalogNo:HJYA0048

Specifications

100μg;200μg

Delivery date

Spot

Target

CD57

Reactivity

Human

Application - After Update

ELISA

Modify

Unmodified

Recommended dilution ratio

ELISA 1:5000-100000

compose

Phosphate-buffered solution

{pboot:if('Camel, chimeric fusion of Nanobody (VHH) and mouse IgG1 Fc domain , recombinantly produced from 293F cell'!='')}

Source

Camel, chimeric fusion of Nanobody (VHH) and mouse IgG1 Fc domain , recombinantly produced from 293F cell

{/pboot:if}

Store

-15°C to -25°C/1 year(Avoid freeze / thaw cycles)

Soncentration

Please check the information on the tube

Clonality

Monoclonal

Clone Number

PN0351

Immunogen

Purified recombinant Human CD57

Specificity

This recombinant monoclonal antibody can detects endogenous levels of CD57 protein.

Gene name

B3GAT1 GLCATP

{pboot:if('Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P)'!='')}

Protein name

Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P)

{/pboot:if}

Organism-1

Human